Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;100(2_suppl):131S-138S.
doi: 10.1177/0145561320953231. Epub 2020 Aug 31.

Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature

Sara Torretta  1   2 , Gianvincenzo Zuccotti  3 , Valentina Cristofaro  1   2 , Jacopo Ettori  1   2 , Lorenzo Solimeno  1   2 , Ludovica Battilocchi  1   2 , Alessandra D'Onghia  1   2 , Anna Bonsembiante  4 , Lorenzo Pignataro  1   2 , Paola Marchisio  1   5 , Pasquale Capaccio  1   6
Affiliations
Review

Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature

Sara Torretta et al. Ear Nose Throat J. 2021 Apr.

Abstract

Objective: The most widely used diagnostic technique for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is real-time reverse transcriptase-polymerase chain reaction (RT-PCR). It can be done on different samples: nasopharyngeal swabs (NPS) or oropharyngeal swabs (OPS), and self-collected saliva. However, negative findings do not rule out infection.

Methods: A review was conceived to discuss advantages and limitations of the available diagnostic modalities for nonserologic diagnosis of SARS-CoV-2 based on RT-PCR; the article also proposes some practical suggestions to improve diagnostic reliability.

Results: A total of 16 papers (corresponding to 452 patients) of the 56 initially identified were included. Most of the papers describe findings from different samples obtained in limited case series; comparative studies are missing.

Conclusions: Diagnostic accuracy of NPS and OPS is suboptimal and the risk of contaminated aerosol dispersal is not negligible. The SARS-CoV-2 RNA can be found in self-collected saliva specimens of many infected patients within 7 to 10 days after symptom onset. There is an urgent need for comparative trials to define the diagnostic modality of choice. Adequate education and training of health care personnel is mandatory.

Keywords: COVID-19; emergency; infection; nasopharynx; swab.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flowchart of article selection.
Figure 2.
Figure 2.
Nasopharyngeal swab execution represented in a drawing (A) and performed in a patient (B); correct placement of the tip of the swab into the nasopharynx documented by means of transnasal videoendoscopy (C).
Figure 3.
Figure 3.
Oropharyngeal swab execution represented in a drawing (A) and performed in a patient (B); correct placement of the tip of the swab at the posterior oropharyngeal wall documented by means of transnasal videoendoscopy (C).
See this image and copyright information in PMC

References

    1. World Health Organization. Coronavirus Disease 2019 (COVID-19). Situation Report-120. Updated June 10, 2020. Accessed June 11, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). Updated July 8, 2020. Accessed April 16, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specim...
    1. Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020;58(7):1070–1076. - PubMed
    1. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. - PMC - PubMed
    1. Food and Drug Administration. New-York SARS-CoV-2. Real-Time RT-PCR Diagnostic Panel-February 29. Updated March 15, 2020. Accessed March 9, 2020. https://www.fda.gov/media/135662/download